The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
FLT3-positive acute myeloid leukemia: Does timed sequential induction therapy influence outcome?
D. Rifai
No relevant relationships to disclose
M. L. Larson
No relevant relationships to disclose
M. C. Keller
No relevant relationships to disclose
P. Venugopal
No relevant relationships to disclose